A. Dolbois

533 total citations
10 papers, 391 citations indexed

About

A. Dolbois is a scholar working on Molecular Biology, Hematology and Infectious Diseases. According to data from OpenAlex, A. Dolbois has authored 10 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Hematology and 1 paper in Infectious Diseases. Recurrent topics in A. Dolbois's work include RNA modifications and cancer (4 papers), Protein Degradation and Inhibitors (4 papers) and Advanced biosensing and bioanalysis techniques (4 papers). A. Dolbois is often cited by papers focused on RNA modifications and cancer (4 papers), Protein Degradation and Inhibitors (4 papers) and Advanced biosensing and bioanalysis techniques (4 papers). A. Dolbois collaborates with scholars based in Switzerland, Sweden and Singapore. A. Dolbois's co-authors include Amedeo Caflisch, Danzhi Huang, R.K. Bedi, Elena Moroz, Yaozong Li, L. Wiedmer, Cristina Nevado, Jian Zhu, Jing Dong and P. Sledz and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Medicinal Chemistry.

In The Last Decade

A. Dolbois

10 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Dolbois Switzerland	9	348	144	36	28	28	10	391
Junchi Hu China	12	392 1.1×	91 0.6×	8 0.2×	22 0.8×	24 0.9×	19	483
L. Wiedmer Switzerland	8	431 1.2×	176 1.2×	49 1.4×	14 0.5×	9 0.3×	12	447
C. Brassington United Kingdom	4	231 0.7×	69 0.5×	7 0.2×	37 1.3×	42 1.5×	4	333
Yao Zhou China	11	299 0.9×	142 1.0×	8 0.2×	14 0.5×	129 4.6×	18	449
Vineet Kumar United States	7	198 0.6×	32 0.2×	8 0.2×	19 0.7×	55 2.0×	12	306
Élie Hadchity France	7	258 0.7×	35 0.2×	11 0.3×	15 0.5×	29 1.0×	9	342
Meng Cao China	11	340 1.0×	148 1.0×	24 0.7×	4 0.1×	32 1.1×	27	449
Kyle D. Konze United States	8	539 1.5×	56 0.4×	6 0.2×	107 3.8×	34 1.2×	10	613
Hui Kang China	5	301 0.9×	46 0.3×	10 0.3×	5 0.2×	11 0.4×	12	363
Wei Lv China	9	307 0.9×	82 0.6×	24 0.7×	5 0.2×	58 2.1×	14	381

Countries citing papers authored by A. Dolbois

Since Specialization

Citations

This map shows the geographic impact of A. Dolbois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Dolbois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Dolbois more than expected).

Fields of papers citing papers by A. Dolbois

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Dolbois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Dolbois. The network helps show where A. Dolbois may publish in the future.

Co-authorship network of co-authors of A. Dolbois

This figure shows the co-authorship network connecting the top 25 collaborators of A. Dolbois. A scholar is included among the top collaborators of A. Dolbois based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Dolbois. A. Dolbois is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Li, Yaozong, et al.. (2022). Structure-based design of ligands of the m6A-RNA reader YTHDC1. SHILAP Revista de lepidopterología. 5. 100057–100057. 11 indexed citations

2.

Moroz, Elena, Danzhi Huang, R.K. Bedi, et al.. (2021). METTL3 Inhibitors for Epitranscriptomic Modulation of Cellular Processes. ChemMedChem. 16(19). 3035–3043. 133 indexed citations

3.

Dolbois, A., et al.. (2021). 1,4,9-Triazaspiro[5.5]undecan-2-one Derivatives as Potent and Selective METTL3 Inhibitors. Journal of Medicinal Chemistry. 64(17). 12738–12760. 105 indexed citations

4.

Dolbois, A., L. Wiedmer, Jing Dong, et al.. (2020). Hitting a Moving Target: Simulation and Crystallography Study of ATAD2 Bromodomain Blockers. ACS Medicinal Chemistry Letters. 11(8). 1573–1580. 7 indexed citations

5.

Bedi, R.K., Danzhi Huang, L. Wiedmer, et al.. (2020). Selectively Disrupting m⁶A-Dependent Protein–RNA Interactions with Fragments. ACS Chemical Biology. 15(3). 618–625. 23 indexed citations

6.

Zhu, Jian, Jing Dong, A. Dolbois, et al.. (2018). Binding Motifs in the CBP Bromodomain: An Analysis of 20 Crystal Structures of Complexes with Small Molecules. ACS Medicinal Chemistry Letters. 9(9). 929–934. 8 indexed citations

7.

Dolbois, A., Xuan Wang, Jian Zhu, et al.. (2018). Chemical Space Expansion of Bromodomain Ligands Guided by in Silico Virtual Couplings (AutoCouple). ACS Central Science. 4(2). 180–188. 26 indexed citations

8.

Felker, Anastasia, Susan Nieuwenhuize, A. Dolbois, et al.. (2016). In Vivo Performance and Properties of Tamoxifen Metabolites for CreERT2 Control. PLoS ONE. 11(4). e0152989–e0152989. 28 indexed citations

9.

Zhao, Hongtao, Graziano Lolli, Jing Dong, et al.. (2016). The “Gatekeeper” Residue Influences the Mode of Binding of Acetyl Indoles to Bromodomains. Journal of Medicinal Chemistry. 59(7). 3087–3097. 35 indexed citations

10.

Evano, Gwilherm, et al.. (2016). A Straightforward Entry to γ-Trifluoromethylated Allenamides and Their Synthetic Applications. Synlett. 27(18). 2575–2580. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact